|
DDX5 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.43659999995993E-06 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.71450000000717E-05 |
| Normal-vs-Stage2 |
1.50070000004554E-06 |
| Normal-vs-Stage3 |
1.40970000006568E-07 |
| Normal-vs-Stage4 |
3.29710000412931E-08 |
| Stage1-vs-Stage2 |
1.243220E-01 |
| Stage1-vs-Stage3 |
6.355500E-03 |
| Stage1-vs-Stage4 |
1.297920E-03 |
| Stage2-vs-Stage3 |
7.560000E-01 |
| Stage2-vs-Stage4 |
3.290200E-01 |
| Stage3-vs-Stage4 |
4.244200E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.6538999999538E-06 |
| Normal-vs-AfricanAmerican |
1.728250E-02 |
| Normal-vs-Asian |
9.844300E-04 |
| Caucasian-vs-AfricanAmerican |
1.994230E-01 |
| Caucasian-vs-Asian |
1.548400E-01 |
| AfricanAmerican-vs-Asian |
8.585600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
6.65119999965214E-07 |
| Normal-vs-Female |
2.64009999995096E-06 |
| Male-vs-Female |
2.980200E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.09089999999979E-05 |
| Normal-vs-Age(41-60Yrs) |
1.98200000001147E-06 |
| Normal-vs-Age(61-80Yrs) |
2.09560000463682E-08 |
| Normal-vs-Age(81-100Yrs) |
6.698000E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.235000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.781360E-04 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.970200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.275500E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.329200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.688800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
2.20789999999527E-05 |
| Classical-VS-Follicular |
1.603190E-01 |
| Classical-VS-Other |
2.190800E-01 |
| Classical-VS-Normal |
3.86530000000551E-05 |
| Tall-VS-Follicular |
2.988200E-02 |
| Tall-VS-Other |
5.629600E-01 |
| Tall-VS-Normal |
3.97230004445248E-09 |
| Follicular-VS-Other |
6.182400E-01 |
| Follicular-VS-Normal |
4.22040000003232E-06 |
| Other-VS-Normal |
8.597500E-04 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.02299999979761E-07 |
| Normal-vs-N1 |
1.404440E-04 |
| N0-vs-N1 |
3.971200E-01 |
|
|
